The potential for OGG1 inhibition to be a therapeutic strategy for pulmonary diseases
- PMID: 38344773
- PMCID: PMC11111349
- DOI: 10.1080/14728222.2024.2317900
The potential for OGG1 inhibition to be a therapeutic strategy for pulmonary diseases
Abstract
Introduction: Pulmonary diseases impose a daunting burden on healthcare systems and societies. Current treatment approaches primarily address symptoms, underscoring the urgency for the development of innovative pharmaceutical solutions. A noteworthy focus lies in targeting enzymes recognizing oxidatively modified DNA bases within gene regulatory elements, given their pivotal role in governing gene expression.
Areas covered: This review delves into the intricate interplay between the substrate-specific binding of 8-oxoguanine DNA glycosylase 1 (OGG1) and epigenetic regulation, with a focal point on elucidating the molecular underpinnings and their biological implications. The absence of OGG1 distinctly attenuates the binding of transcription factors to cis elements, thereby modulating pro-inflammatory or pro-fibrotic transcriptional activity. Through a synergy of experimental insights gained from cell culture studies and murine models, utilizing prototype OGG1 inhibitors (O8, TH5487, and SU0268), a promising panorama emerges. These investigations underscore the absence of cytotoxicity and the establishment of a favorable tolerance profile for these OGG1 inhibitors.
Expert opinion: Thus, the strategic targeting of the active site pocket of OGG1 through the application of small molecules introduces an innovative trajectory for advancing redox medicine. This approach holds particular significance in the context of pulmonary diseases, offering a refined avenue for their management.
Keywords: Epigenetic regulation; NF-κB; OGG1 inhibitor; airway remodeling; chronic lung inflammation.
Conflict of interest statement
Declaration of interest
The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
Similar articles
-
Epigenetic regulation of TIMP1 expression by 8-oxoguanine DNA glycosylase-1 binding to DNA:RNA hybrid.FASEB J. 2019 Dec;33(12):14159-14170. doi: 10.1096/fj.201900993RR. Epub 2019 Oct 25. FASEB J. 2019. PMID: 31652414 Free PMC article.
-
TH5487, a small molecule inhibitor of OGG1, attenuates pulmonary fibrosis by NEDD4L-mediated OGG1 degradation.Chem Biol Interact. 2022 Aug 1;362:109999. doi: 10.1016/j.cbi.2022.109999. Epub 2022 May 30. Chem Biol Interact. 2022. PMID: 35654123
-
Small-molecule inhibitor of OGG1 suppresses proinflammatory gene expression and inflammation.Science. 2018 Nov 16;362(6416):834-839. doi: 10.1126/science.aar8048. Science. 2018. PMID: 30442810 Free PMC article.
-
Targeting 8-oxoguanine DNA glycosylase-1 (OGG1) as a therapeutic strategy in inflammatory-related diseases.Immunopharmacol Immunotoxicol. 2024 Oct;46(5):685-694. doi: 10.1080/08923973.2024.2391471. Epub 2024 Aug 20. Immunopharmacol Immunotoxicol. 2024. PMID: 39164801 Review.
-
OGG1: An emerging multifunctional therapeutic target for the treatment of diseases caused by oxidative DNA damage.Med Res Rev. 2024 Nov;44(6):2825-2848. doi: 10.1002/med.22068. Epub 2024 Aug 9. Med Res Rev. 2024. PMID: 39119702 Review.
Cited by
-
8-Oxoguanine DNA Glycosylase1 conceals oxidized guanine in nucleoprotein-associated RNA of respiratory syncytial virus.PLoS Pathog. 2024 Oct 16;20(10):e1012616. doi: 10.1371/journal.ppat.1012616. eCollection 2024 Oct. PLoS Pathog. 2024. PMID: 39413143 Free PMC article.
References
-
- Dizdaroglu M. Base-excision repair of oxidative DNA damage by DNA glycosylases. Mutat Res 2005; 591:45–59. - PubMed
-
- Girard PM, D'Ham C, Cadet J, Boiteux S. Opposite base-dependent excision of 7,8-dihydro-8-oxoadenine by the Ogg1 protein of Saccharomyces cerevisiae. Carcinogenesis 1998; 19:1299–1305. - PubMed
-
- Bruner SD, Norman DP, Verdine GL. Structural basis for recognition and repair of the endogenous mutagen 8-oxoguanine in DNA. Nature 2000; 403:859–866. - PubMed
-
- Yang W. Structure and mechanism for DNA lesion recognition. Cell Res 2008; 18:184–197. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials